Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 26 , ISSUE 2 ( February, 2022 ) > List of Articles

LETTER TO THE EDITOR

Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links

Praneet Vashishtha, Nipun Gupta, Ravi Wadke, Priya Taank

Citation Information : Vashishtha P, Gupta N, Wadke R, Taank P. Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links. Indian J Crit Care Med 2022; 26 (2):248-249.

DOI: 10.5005/jp-journals-10071-23930

License: CC BY-NC 4.0

Published Online: 09-02-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract
HTML PDF Share
  1. Delly F, Syed MJ, Lisak RP, Zutshi D. Myasthenic crisis in COVID-19. J Neurol Sci 2020;414:116888. DOI: 10.1016/j.jns.2020.116888.
  2. International MG/COVID-19 Working Group, Jacob S, Muppidi S, Guidon A, Guptill J, Hehir M, et al. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci 2020;412:116803. DOI: 10.1016/j.jns.2020.116803.
  3. Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology 2020;94(22):959–969. DOI: 10.1212/WNL.0000000000009566.
  4. Bonilla FA. Adverse effects of immunoglobulin G therapy: thromboembolism and haemolysis. Clin Exp Immunol 2014;178 (Suppl. 1):72–74. DOI: 10.1111/cei.12518.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.